GSK CFO Interviewed on Q2 2015 Results
29 July 2015 - 9:47PM
PR Newswire (US)
LONDON, July 29, 2015 /PRNewswire/ --
Commenting on GSK's Q2 performance, the first since the Novartis
transaction closed, CFO Simon
Dingemans reveals sales rose during the period and that
newly acquired businesses are performing in line with expectations.
Ahead of a November R&D update day he reiterates the company's
commitment to sustainable innovation.
The interview and transcript are available now on
http://video.merchantcantos.com
MerchantCantos produces in-depth interviews, documentaries and
webcasts with senior company executives. If you would like to
contact us, please email prnsupport@merchantcantos.com or phone
+44-(0)207-936-1352.
SOURCE GlaxoSmithKline
Copyright 2015 PR Newswire
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024